Fig. 4

The prognostic assessment of the signature in the TCGA cohort. aThe Kaplan–Meier survival analysis and time-dependent ROC analysis of the signature for predicting the OS of patients in the TCGA cohort. b The Kaplan–Meier survival analysis and time-dependent ROC analysis of the signature for predicting the PFS of patients in the TCGA cohort. c The Kaplan–Meier survival analysis and time-dependent ROC analysis of the signature for predicting the DSS of patients in the TCGA cohort. d The Kaplan–Meier survival analysis and time-dependent ROC analysis of the signature for predicting the DFS of patients in the TCGA cohort